Boots, the 177‑year‑old British pharmacy and health‑and‑beauty retailer, has been transferred to the ownership of Canada’s billionaire Weston family in a deal valued at $8.9 billion (£6.7 billion). The sale marks the latest chapter in a series of ownership changes for the iconic high‑street brand, and it raises a number of questions about the future direction of the chain.
Background and recent performance
Founded by John Boot in Nottingham in 1849, the company has grown from a single herbalist shop into a network of roughly 1,800 stores across the United Kingdom and Ireland, employing about 51,000 people. In its most recent annual results, Boots generated £7.5 billion in sales, a 3.2 % increase on the previous year, despite challenges such as lower footfall caused by more people working from home.
Boots has diversified its offering beyond traditional pharmacy services to include health and beauty products, meal deals, travel accessories, and a popular loyalty programme launched in 1997 – the Advantage Card. The chain also provides vaccinations, eye and hearing tests, and has played a visible role during national health crises such as the COVID‑19 pandemic.
The deal details
The transaction is being executed by Wittington Investments, the holding company of the Weston family, in partnership with Fairfax Financial Holdings, a Toronto‑based firm. The purchase includes Boots’ retail operations in the UK and Ireland, Boots Opticians, the No7 beauty company, and its Thailand and franchised businesses. The deal is expected to be finalised in early 2027.
Sycamore Partners, the U.S. private‑equity firm that owned Boots for only 18 months, will retain the Mexican pharmacy chain Farmacias Benavides and the German logistics arm Alliance Healthcare Deutschland. The Pessina family, previously involved through Stefano Pessina, will also keep the German and Mexican interests.
Weston family patriarch Wesley Weston will become chairman of Boots, signalling a hands‑on approach. The Westons are already prominent owners of the Canadian grocery chain Loblaws, the pharmacy chain Shoppers Drug Mart, and previously owned the London department store Selfridges (sold for $4 billion). Their broader corporate footprint includes a controlling stake in Associated British Foods, the parent of Primark.
Implications for Boots
Retail expert Catherine Shuttleworth expects that shoppers will not see immediate changes to store layouts, but she anticipates that the new owners will invest in an "improved shopping experience" over time. The Westons have highlighted health and beauty as a "massive area for growth" and have pledged to upgrade shops and expand healthcare services.
With stable, long‑term ownership, the Westons aim to provide "further capital investment" and a renewed operating focus, according to a statement from Wesley Weston. This could address the "unhelpful distraction" caused by frequent ownership changes, a sentiment echoed by Shuttleworth.
Wider retail landscape
The acquisition reflects a broader trend of consolidation in the retail and pharmacy sectors, where large, diversified groups seek to combine scale with specialised expertise. By adding Boots to their portfolio, the Westons deepen their presence in both grocery and health‑care markets, potentially creating synergies with Shoppers Drug Mart and Loblaws.
For competitors, the deal underscores the importance of investing in omnichannel capabilities and health‑focused services to retain footfall. Boots’ continued emphasis on its loyalty programme and health services may set a benchmark for other high‑street retailers navigating the shift toward online and experience‑driven shopping.
Uncertainties and next steps
While the deal promises fresh capital, several uncertainties remain:
- Regulatory approval: The transaction must clear UK competition authorities, which could impose conditions on store closures or service offerings.
- Integration timeline: With completion slated for early 2027, the pace at which the Westons can implement upgrades and expand healthcare services will be closely watched.
- Employee impact: Any restructuring could affect the 51,000‑strong workforce, especially in areas where stores have already been closed.
Overall, the sale of Boots to the Weston family represents a significant infusion of capital and strategic direction for a storied British brand. How the new owners balance growth ambitions with the legacy of community‑focused pharmacy services will shape the chain’s trajectory in the coming years.